Suppr超能文献

一项比较肌肉注射长效帕利哌酮棕榈酸酯与口服抗精神病药治疗有暴力行为风险的精神分裂症患者的随机、前瞻性、阳性对照研究。

A randomized, prospective, active-controlled study comparing intramuscular long-acting paliperidone palmitate versus oral antipsychotics in patients with schizophrenia at risk of violent behavior.

机构信息

Wuhan, Mental Health Center, Wuhan, China.

Wuhan, Mental Health Center, Wuhan, China..

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Feb 8;129:110897. doi: 10.1016/j.pnpbp.2023.110897. Epub 2023 Nov 14.

Abstract

OBJECTIVE

Paliperidone palmitate (PP) is an effective long-acting antipsychotic injection, but its impact on the behavior of schizophrenia patients with dangerous tendencies requires further investigation. This study aims to explore the effects of long-term antipsychotic treatment on this population in the community.

METHODS

This 49-week, randomized controlled trial was conducted across 21 communities in Wuhan and enrolled 134 schizophrenia patients at risk for violent behavior. With a fixed block size of 10, participants were randomly assigned to receive either intramuscular PP 1-month formulation (PP1M) or oral antipsychotic medication (OAP) at a 1:1 ratio. Changes in patients' risk for violent/aggressive behavior, family burden, social, and cognitive functioning were measured using VRAPP, MOAS, PANSS, FBS, PSP, and RBANS scales from baseline to endpoint. Longitudinal data from multiple repeated measures were analyzed using linear mixed-effects models.

RESULTS

The study protocol was completed by 77.6% of the patients overall. Significant improvements were observed in the risk assessment scores, MOAS total score, PANSS total score, PSP total score, and FBS total score of patients in the PP1M group from baseline to the end of treatment (all P < 0.05). Importantly, compared to patients in the OAP group, the improvements in these measures were also significantly greater in the PP1M group. Commonly observed AEs, such as hyperprolactinemia (70.3% vs. 62.65%) and muscle tension (45.3% vs. 57.8%), were considered to be the PP-related AEs. Nonetheless, the differences between the two groups did not reach statistical significance, and no new safety concerns emerged.

CONCLUSIONS

Our study suggests that PP long-acting injection (LAI) is a safe and effective treatment option for community-dwelling schizophrenia patients with impulsive violence and risky behaviors.

摘要

目的

棕榈酸帕利哌酮(PP)是一种有效的长效抗精神病注射剂,但它对具有危险倾向的精神分裂症患者行为的影响仍需进一步研究。本研究旨在探讨长效抗精神病药物治疗在社区环境中对这一人群的影响。

方法

这是一项为期 49 周、在武汉 21 个社区进行的随机对照试验,共纳入 134 名有暴力行为风险的精神分裂症患者。采用固定分组大小为 10 的方法,将参与者随机分为肌肉注射 1 个月剂型的 PP(PP1M)组或口服抗精神病药物(OAP)组,比例为 1:1。使用 VRAPP、MOAS、PANSS、FBS、PSP 和 RBANS 量表,从基线到终点测量患者暴力/攻击行为风险、家庭负担、社会和认知功能的变化。使用线性混合效应模型对多重复测量的纵向数据进行分析。

结果

总体而言,完成研究方案的患者占 77.6%。与基线相比,PP1M 组患者的风险评估评分、MOAS 总分、PANSS 总分、PSP 总分和 FBS 总分均显著改善(均 P<0.05)。重要的是,与 OAP 组患者相比,PP1M 组患者在这些指标上的改善也更为显著。常见的不良反应,如高催乳素血症(70.3%比 62.65%)和肌肉紧张(45.3%比 57.8%),被认为是与 PP 相关的不良反应。然而,两组间的差异未达到统计学意义,也未出现新的安全性问题。

结论

本研究表明,PP 长效注射剂(LAI)是一种安全有效的治疗社区居住的有冲动暴力和危险行为的精神分裂症患者的选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验